Private Advisor Group’s Bristol-Myers Squibb BMY Stock Holding History

Private Advisor Group’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$16.3M	Sell	268,500 -820	-0.3%	-$47.8K	0.08%	276
2025 Q4	$14.5M	Buy	269,320 +14,941	+6%	+$719K	0.07%	297
2025 Q3	$11.5M	Buy	254,379 +2,759	+1%	+$129K	0.06%	341
2025 Q2	$11.6M	Sell	251,620 -29,014	-10%	-$1.42M	0.06%	317
2025 Q1	$17.1M	Buy	280,634 +30,323	+12%	+$1.77M	0.1%	199
2024 Q4	$14.2M	Sell	250,311 -3,945	-2%	-$220K	0.08%	232
2024 Q3	$13.2M	Sell	254,256 -10,589	-4%	-$497K	0.08%	229
2024 Q2	$11M	Sell	264,845 -6,003	-2%	-$269K	0.07%	248
2024 Q1	$14.7M	Buy	270,848 +6,040	+2%	+$308K	0.11%	177
2023 Q4	$13.6M	Sell	264,808 -13,175	-5%	-$692K	0.11%	183
2023 Q3	$16.1M	Sell	277,983 -8,206	-3%	-$503K	0.14%	135
2023 Q2	$18.1M	Sell	286,189 -9,187	-3%	-$616K	0.16%	130
2023 Q1	$20.5M	Sell	295,376 -7,505	-2%	-$529K	0.2%	109
2022 Q4	$9.24M	Buy	302,881 +7,541	+3%	+$569K	0.47%	41
2022 Q3	$21M	Sell	295,340 -34,715	-11%	-$2.52M	0.24%	89
2022 Q2	$25.4M	Sell	330,055 -85	-0%	-$6.47K	0.23%	95
2022 Q1	$24.1M	Sell	330,140 -2,181	-0.7%	-$146K	0.18%	113
2021 Q4	$20.7M	Sell	332,321 -206,907	-38%	-$12.1M	0.16%	132
2021 Q3	$31.9M	Buy	539,228 +191,843	+55%	+$12.6M	0.2%	97
2021 Q2	$23.2M	Sell	347,385 -41,475	-11%	-$2.7M	0.2%	94
2021 Q1	$24.5M	Sell	388,860 -40,028	-9%	-$2.49M	0.23%	86
2020 Q4	$26.6M	Buy	428,888 +60,935	+17%	+$3.75M	0.28%	71
2020 Q3	$22M	Buy	367,953 +2,553	+0.7%	+$154K	0.29%	69
2020 Q2	$21.5M	Buy	365,400 +20,334	+6%	+$1.22M	0.3%	68
2020 Q1	$19.2M	Sell	345,066 -410	-0.1%	-$25.1K	0.35%	55
2019 Q4	$22.2M	Buy	345,476 +156,869	+83%	+$8.98M	0.34%	54
2019 Q3	$9.71M	Buy	188,607 +23,859	+14%	+$1.12M	0.15%	148
2019 Q2	$7.47M	Buy	164,748 +9,030	+6%	+$421K	0.14%	170
2019 Q1	$7.48M	Sell	155,718 -3,833	-2%	-$191K	0.15%	150
2018 Q4	$8.29M	Sell	159,551 -11,967	-7%	-$643K	0.2%	116
2018 Q3	$10.6M	Sell	171,518 -4,438	-3%	-$263K	0.22%	103
2018 Q2	$9.72M	Buy	175,956 +61,730	+54%	+$3.33M	0.16%	56
2018 Q1	$7.23M	Sell	114,226 -14,071	-11%	-$905K	0.28%	78
2017 Q4	$7.94M	Sell	128,297 -102,988	-45%	-$6.44M	0.34%	68
2017 Q3	$14.8M	Buy	231,285 +12,772	+6%	+$746K	0.37%	56
2017 Q2	$12.2M	Sell	218,513 -66,881	-23%	-$3.64M	0.33%	65
2017 Q1	$12M	Buy	285,394 +84,167	+42%	+$4.62M	0.33%	64
2016 Q4	$11.4M	Sell	201,227 -1,623	-0.8%	-$88.7K	0.37%	56
2016 Q3	$11.2M	Buy	202,850 +6,491	+3%	+$417K	0.46%	40
2016 Q2	$14.5M	Buy	196,359 +18,114	+10%	+$1.28M	0.59%	31
2016 Q1	$11.5M	Buy	178,245 +14,802	+9%	+$933K	0.56%	34
2015 Q4	$11.2M	Buy	163,443 +3,974	+2%	+$263K	0.54%	34
2015 Q3	$9.44M	Buy	159,469 +26,790	+20%	+$1.7M	0.52%	41
2015 Q2	$8.83M	Buy	132,679 +8,470	+7%	+$558K	0.42%	47
2015 Q1	$8.01M	Buy	124,209 +10,273	+9%	+$643K	0.46%	41
2014 Q4	$6.73M	Buy	113,936 +9,139	+9%	+$515K	0.43%	52
2014 Q3	$5.36M	Buy	104,797 +13,841	+15%	+$691K	0.37%	56
2014 Q2	$4.41M	Buy	90,956 +4,134	+5%	+$204K	0.38%	62
2014 Q1	$4.51M	Buy	86,822 +14,618	+20%	+$778K	0.48%	44
2013 Q4	$3.84M	Buy	+72,204	New	+$3.68M	0.43%	47

Other funds holding BMY

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Private Advisor Group's BMY Position: Q1 2026 in Review

Private Advisor Group reduced its Bristol-Myers Squibb (BMY) stake by 0.3% in Q1 2026, selling an estimated $47.8K and leaving 268,500 shares worth $16.3M. The position accounts for 0.08% of the portfolio, ranked #276.

Private Advisor Group first reported a position in BMY in Q4 2013 and has held it in 50 quarters since. The position peaked at $31.9M in Q3 2021. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

Private Advisor Group held 268,500 shares of Bristol-Myers Squibb worth $16.3M as of Q1 2026.
Private Advisor Group sold 820 Bristol-Myers Squibb shares in Q1 2026, an estimated $47.8K.
Bristol-Myers Squibb made up 0.08% of Private Advisor Group's portfolio in Q1 2026, its #276 holding.
Private Advisor Group first reported a position in Bristol-Myers Squibb in Q4 2013 and has held it in 50 quarters since.
Private Advisor Group's Bristol-Myers Squibb position peaked at $31.9M in Q3 2021.
2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Private Advisor Group's 13F filing for Q1 2026, filed 27 Apr 2026.